Tibet Cheezheng Tibetan Medicine Co Ltd Financial Flexibility Index
Tibet Cheezheng Tibetan Medicine Co Ltd financial flexibility index. Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥76.38 Million (operating CF CN¥34.69 Million minus capex CN¥41.69 Million) represents 0% of total liabilities (CN¥1.78 Billion). Explore reinvestment intensity of Tibet Cheezheng Tibetan Medicine Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Financial flexibility index of Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2025. Historical Financial Flexibility Index trend for Tibet Cheezheng Tibetan Medicine Co Ltd across 20 annual periods. Check cash flow reinvestment rate of Tibet Cheezheng Tibetan Medicine Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Tibet Cheezheng Tibetan Medicine Co Ltd Financial Flexibility Index by Year (2006–2025)
Tibet Cheezheng Tibetan Medicine Co Ltd financial flexibility index by year from 2006 to 2025. Year-by-year free cash flow to debt coverage for Tibet Cheezheng Tibetan Medicine Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Tibet Cheezheng Tibetan Medicine Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | CN¥882.78 Million | CN¥729.70 Million | CN¥1.92 Billion | ▲ +72.8% |
| 2024 | 0.27x | CN¥712.19 Million | CN¥456.75 Million | CN¥2.68 Billion | ▼ -27.5% |
| 2023 | 0.37x | CN¥928.22 Million | CN¥693.41 Million | CN¥2.53 Billion | ▲ +64.4% |
| 2022 | 0.22x | CN¥558.08 Million | CN¥285.69 Million | CN¥2.50 Billion | ▼ -54.8% |
| 2021 | 0.49x | CN¥1.16 Billion | CN¥1.03 Billion | CN¥2.35 Billion | ▲ +56.2% |
| 2020 | 0.32x | CN¥577.62 Million | CN¥238.65 Million | CN¥1.82 Billion | ▼ -50.1% |
| 2019 | 0.63x | CN¥458.22 Million | CN¥405.95 Million | CN¥722.20 Million | ▼ -73.0% |
| 2018 | 2.35x | CN¥628.34 Million | CN¥499.40 Million | CN¥267.54 Million | ▲ +219.6% |
| 2017 | 0.73x | CN¥295.95 Million | CN¥229.83 Million | CN¥402.78 Million | ▼ -58.1% |
| 2016 | 1.75x | CN¥569.08 Million | CN¥389.20 Million | CN¥324.33 Million | ▲ +127.8% |
| 2015 | 0.77x | CN¥322.72 Million | CN¥257.81 Million | CN¥419.05 Million | ▼ -52.5% |
| 2014 | 1.62x | CN¥392.42 Million | CN¥310.95 Million | CN¥242.20 Million | ▼ -48.7% |
| 2013 | 3.16x | CN¥272.86 Million | CN¥198.48 Million | CN¥86.34 Million | ▲ +10.5% |
| 2012 | 2.86x | CN¥231.32 Million | CN¥169.67 Million | CN¥80.90 Million | ▲ +204.0% |
| 2011 | 0.94x | CN¥75.25 Million | CN¥-11.74 Million | CN¥80.01 Million | ▼ -32.5% |
| 2010 | 1.39x | CN¥154.23 Million | CN¥96.91 Million | CN¥110.72 Million | ▲ +10.8% |
| 2009 | 1.26x | CN¥192.02 Million | CN¥175.58 Million | CN¥152.68 Million | ▲ +38.8% |
| 2008 | 0.91x | CN¥89.72 Million | CN¥65.93 Million | CN¥99.02 Million | ▼ -12.0% |
| 2007 | 1.03x | CN¥121.92 Million | CN¥91.43 Million | CN¥118.37 Million | ▲ +164.1% |
| 2006 | 0.39x | CN¥52.40 Million | CN¥38.50 Million | CN¥134.37 Million | — |